Welcome to our dedicated page for REZOLVE AI PLC SEC filings (Ticker: RZLVW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on REZOLVE AI PLC's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into REZOLVE AI PLC's regulatory disclosures and financial reporting.
Rezolve AI plc entered into a registered direct offering to sell 62,500,000 ordinary shares at $4.00 per share, for gross proceeds of $250.0 million before fees and expenses. The shares are being issued under an effective Form F-3 registration statement and related prospectus supplement, with closing expected on January 21, 2026, subject to customary conditions.
The company plans to use the net proceeds to accelerate investment in its sales organization, pursue potential accretive M&A opportunities, and for general corporate and working capital purposes. Rezolve AI agreed not to issue or agree to issue additional ordinary shares or equivalents, or file new registration statements, for 30 days after closing, subject to exceptions. Placement agents will receive a 5.0% cash fee on the aggregate gross proceeds plus up to $120,000 of legal fees and up to $10,000 of non-accountable expenses.
Rezolve AI plc has agreed to sell 37,000,000 ordinary shares to qualified institutional investors in a private placement at $5.40 per share. This pricing implies aggregate gross proceeds of about $200 million, before placement agent fees and other offering costs. The closing is expected on or about September 25, 2025, subject to customary closing conditions.
The company plans to use the new capital to accelerate investment in its sales organization, pursue potential accretive M&A opportunities, and support working capital and general corporate purposes. A.G.P./Alliance Global Partners is acting as lead agent and H.C. Wainwright & Co. as co-lead agent for the transaction, which is being conducted under U.S. private placement exemptions and is not registered under the Securities Act.
Rezolve AI plc reports that holders of all 5,000,000 warrants issued in a registered offering in December 2024 have exercised their warrants. Each warrant was exercised at $3.00 for one ordinary share, resulting in 5,000,000 new ordinary shares and generating aggregate gross proceeds of $15 million for the company. The early expiration date of these warrants was triggered after the company’s share VWAP stayed at or above $6.00 for five consecutive trading days in September.